News Cytophage Technologies Ltd.

Equities

CYTO

CA2328211081

Delayed Toronto S.E. Other stock markets 03:44:19 2024-05-21 pm EDT			5-day change	1st Jan Change
0.52 ^CAD	+1.96%		+31.65%	-26.20%

Apr. 30	Cytophage Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 16	Cytophage Technologies Ltd. Appoints Michael D. Cochrane as Newest Member of Board of Directors	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytophage Announces Fiscal Year End 2023 Results	Apr. 30	AQ
Cytophage Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Cytophage Technologies Ltd. Appoints Michael D. Cochrane as Newest Member of Board of Directors	Apr. 16	CI
Cytophage Appoints New Board Director	Apr. 16	AQ
Cytophage Technologies Ltd. Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	Apr. 02	CI
Cytophage Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	Apr. 02	AQ
Cytophage Provides Bacteriophages for Landmark Treatment of Joint Replacement Infection in Canada	Mar. 01	AQ
Cytophage Technologies Ltd. Provides Update on Upcoming Product for Egg Production in Canada	Feb. 12	CI
Cytophage Update on Upcoming Product for Egg Production in Canada	Feb. 12	AQ
Cytophage Technologies Inc. completed the acquisition of Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.	Feb. 01	CI
Cuspis Capital III Ltd. Announces Closing of Concurrent Financing by Cytophage Technologies Inc., Receipt of TSXV Conditional Approval, and Certain Loans	Dec. 22	AQ
Cuspis Capital III Ltd. announced that it has received CAD 2.5 million in funding	Dec. 21	CI
Cuspis Capital III Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
Cuspis Capital III Ltd. and Cytophage Technologies Inc. Announce Execution of Business Combination Agreement and Concurrent Financing	Nov. 06	AQ
Cytophage Technologies Ltd. announced that it expects to receive CAD 2.5 million in funding	Nov. 05	CI
Cuspis Capital III Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-27	CI
Canadian Investment Regulatory Organization Trading Halt - CIII.P	23-06-01	AQ
Cytophage Technologies Inc. entered into a letter of intent to acquire Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.	23-05-31	CI
Cytophage Technologies Inc. announced that it expects to receive $5 million in funding from Cuspis Capital III Ltd.	23-05-31	CI
Cuspis Capital III Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cytophage Technologies Ltd.

Equities

CYTO

CA2328211081

Summary

Filters